Exopharm
is headquartered in Melbourne, Victoria. Ian Dixon is the Managing Director of Exopharm. Exopharm has acquired 1 companies, with the most recent being Tryptamine Therapeutics Limited for an undisclosed amount on Mar 2024. Exopharm has 3 followers on Owler.Exopharm
is headquartered in Melbourne, Victoria. Ian Dixon is the Managing Director of Exopharm. Exopharm has acquired 1 companies, with the most recent being Tryptamine Therapeutics Limited for an undisclosed amount on Mar 2024. Exopharm has 3 followers on Owler.
Managing Director
Ian Dixon
News
May 01, 2024
FinanzNachrichten
Exopharm: Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement
Mar 08, 2024
News n Releases
Press Release: Exopharm : Exopharm set to acquire Tryp Therapeutics - NewsnReleases
Jan 26, 2024
FinanzNachrichten
Exopharm: Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
Dec 11, 2023
FinanzNachrichten
Exopharm: Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
Dec 11, 2023
Benzinga
Exopharm: Merger Alert: Tryp Therapeutics Signs With Australian Drug Delivery Innovator, Details Here
Feb 13, 2023
The Market Herald
Exopharm: Exopharm (ASX:EX1) shares topple amid attempts to raise funds
Nov 24, 2022
BioPharma-Reporter
Exopharm: 'Game-changing' partnership announced for emerging exosome field
Nov 23, 2022
News-Medical
Exopharm: Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology
Nov 23, 2022
Exopharm Blog
Exopharm Blog 'Limitless future of RNA therapeutics' - and what that means for exosomes and Exopharm (ASX:EX1)
Nov 23, 2022
Exopharm Blog
Exopharm Blog ‘Limitless future of RNA therapeutics’ – and what that means for exosomes and Exopharm (ASX:EX1)